Azenta Inc (AZTA)

NASD · Healthcare · Medical Instruments & Supplies · USA

Azenta Inc is a mid cap company (market value between $2 billion and $10 billion) in the Medical Instruments & Supplies industry.

Azenta provides automated storage systems, cryogenic equipment and genomic services to pharmaceutical, biotechnology and research institutions worldwide. The company operates through two segments: Sample Management Solutions, offering storage products, sample repository services and related consumables; and Multiomics, providing gene sequencing, synthesis and analysis services. It serves customers across North America, Asia and Europe.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Azenta Inc stock.

Our verdict on AZTA

Overvalued: intrinsic value $28.21 per share, market price $45.81, margin of safety -62.4% (as of 2026-11-17).

A 1.5x revenue multiple, discounted for its losses, values the shares at $28.21; the price of $45.81 is 62% above that value.

ETFs with the most weight in AZTA

17 more funds hold it; the full list is part of the paid plan.

More on AZTA

Browse

Peers in Medical Instruments & Supplies

All 52 Medical Instruments & Supplies stocks

Cheaper than AZTA in Medical Instruments & Supplies

9 more in this industry show a wider margin of safety.

Is AZTA undervalued or overvalued?

AZTA is overvalued (as of the 2026-11-17 close). A 1.5x revenue multiple, discounted for its losses, values the shares at $28.21; the price of $45.81 is 62% above that value.

What is the intrinsic value of AZTA?

$28.21 per share (as of the 2026-11-17 close), against a market price of $45.81. That is a margin of safety of -62.4%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.